Illness	Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	125
Obstructive and reflux uropathy - Crossing vessel and stricture of ureter without hydronephrosis (N13.5)	108
Unspecified haematuria (R31)	108
Calculus of kidney and ureter - Calculus of ureter (N20.1)	100
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	99
Calculus of kidney and ureter - Calculus of kidney (N20.0)	98
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	85
Hyperplasia of prostate (N40)	64
Malignant neoplasm of prostate (C61)	38
Obstructive uropathy and refluxuropathy - Pyonephrosis - Hydronephrosis in ureteropelvic obstruction with infection of the kidney (N13.60)	36

Top 10 treatments

Treatment	Number
Computer-assisted analysis of the images with 3D-analysis (3-990)	428
Injection or administration of medicines into the urinary bladder (8-132.3)	400
Computed tomography (CT) of the abdomen without contrast medium (3-207)	299
Computed tomography (CT) of the pelvis without contrast medium (3-206)	298
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	188
Insertion, exchange or removal of a ureteral stent (8-137.00)	181
Insertion, exchange or removal of a ureteral stent (8-137.10)	179
(9-984.8)	153
Magnetic resonance imaging (MRI) of the blood vessels apart from main arteries and veins without contrast medium (3-808)	151
(9-984.7)	143

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01
CQ07	Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org
CQ27
CQ31

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
132	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
104	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
104	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Doctoral supervision